Occurrence and species level diagnostics of Campylobacter spp., enteric Helicobacter spp. and Anaerobiospirillum spp. in healthy and diarrheic dogs and cats

Vet Microbiol. 2008 Jun 22;129(3-4):304-14. doi: 10.1016/j.vetmic.2007.11.014. Epub 2007 Nov 22.

Abstract

In order to study the occurrence and co-infection of different species of Campylobacter, enteric Helicobacter and Anaerobiospirillum in dogs and cats and define a possible association between these microrganisms and gastrointestinal disorders, 190 dogs and 84 cats, either healthy or with diarrhea, were sampled between 2002 and 2003. Thirty-three C. upsaliensis, 17 C. jejuni, 2 C. helveticus, 1 C. lari isolates from dogs and 14 C. helveticus, 7 C. jejuni, 6 C. upsaliensis isolates from cats were identified using species-specific PCR and phenotypic tests. Whole cell protein profile analysis, phenotypic tests, PCR-RFLP of gyrB and a phylogenetic study of partial groEL and 16S rRNA sequences were used to identify 37 H. bilis, 22 H. canis and 14 H. cinaedi in dogs and 12 H. canis, 5 H. bilis and 2 H. cinaedi in cats. Whole cell protein profile analysis, phenotypic tests and species-specific PCR of 16S rRNA were used to identify 14 A. succiniciproducens, 12 A. thomasii isolates and one unidentified Anaerobiospirillum sp. isolate in dogs and 3 A. thomasii isolates in cats. Fifty-two animals (19%) were positive for the isolation of more than one genus. No significant statistical correlation was found between any isolates of Campylobacter, Helicobacter or Anaerobiospirillum spp. or the various co-infection rates, and the presence of diarrhea in either dogs or cats. Campylobacter isolates were also tested for antibiotic resistance using the agar dilution method.

MeSH terms

  • Anaerobiospirillum / classification
  • Anaerobiospirillum / drug effects
  • Anaerobiospirillum / isolation & purification
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Campylobacter / classification
  • Campylobacter / drug effects
  • Campylobacter / isolation & purification
  • Campylobacter Infections / diagnosis
  • Campylobacter Infections / drug therapy
  • Campylobacter Infections / microbiology
  • Campylobacter Infections / veterinary
  • Cat Diseases / diagnosis
  • Cat Diseases / drug therapy
  • Cat Diseases / microbiology*
  • Cats / microbiology*
  • Diarrhea / diagnosis
  • Diarrhea / drug therapy
  • Diarrhea / microbiology
  • Diarrhea / veterinary*
  • Dog Diseases / diagnosis
  • Dog Diseases / drug therapy
  • Dog Diseases / microbiology*
  • Dogs / microbiology*
  • Dose-Response Relationship, Drug
  • Drug Resistance, Bacterial
  • Gram-Negative Bacterial Infections / diagnosis
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology
  • Gram-Negative Bacterial Infections / veterinary*
  • Helicobacter / classification
  • Helicobacter / drug effects
  • Helicobacter / isolation & purification
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter Infections / veterinary
  • Microbial Sensitivity Tests / veterinary
  • Molecular Sequence Data
  • Phylogeny
  • Polymerase Chain Reaction / methods
  • Polymerase Chain Reaction / veterinary
  • Prevalence
  • RNA, Ribosomal, 16S / genetics
  • Species Specificity

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 16S

Associated data

  • GENBANK/EF428122
  • GENBANK/EF569185
  • GENBANK/EU144017
  • GENBANK/EU144018
  • GENBANK/EU144019
  • GENBANK/EU233438
  • GENBANK/EU233439
  • GENBANK/EU233440
  • GENBANK/EU233441
  • GENBANK/EU233442
  • GENBANK/EU233443
  • GENBANK/EU233444
  • GENBANK/EU233445
  • GENBANK/EU233446
  • GENBANK/EU233447
  • GENBANK/EU233448
  • GENBANK/EU233449
  • GENBANK/EU233450
  • GENBANK/EU233451
  • GENBANK/EU233452
  • GENBANK/EU233453
  • GENBANK/EU233454